Bico's Biosero Secures Major Contract Worth 143.6 Million SEK
Bico's subsidiary Biosero has secured a 143.6 million SEK contract with a global pharmaceutical firm.
- • Biosero signed a framework agreement in August 2025.
- • First purchase orders total 15.2 million dollars.
- • Contract highlights Bico's growth in laboratory automation.
- • Announcement made via press release.
Key details
Biosero, a subsidiary of Bico, has landed a significant framework agreement with a prominent global pharmaceutical company. Announced on September 5, 2025, the deal showcases Biosero's growing footprint in integrated laboratory automation solutions. Initially, this agreement has led to purchase orders aggregating approximately 15.2 million dollars, which is around 143.6 million Swedish kronor. This development signals Bico's capability to attract lucrative contracts within the competitive pharmaceutical industry, reinforcing the importance of its operations in the biotechnology sector.
This article was synthesized and translated from native language sources to provide English-speaking readers with local perspectives.
Latest news
Moa Ilar Secures Second Place at Davos World Cup 10 km Freestyle
Truls Möregårdh Narrowly Loses to Tomokazu Harimoto in Thrilling 2025 WTT Finals
Sweden’s Tre Kronor Goes Undefeated to Win 2025 Swiss Hockey Games with Erik Brännström Shining
Anna Magnusson Extends Impressive Biathlon Podium Streak in Hochfilzen
Struggles Continue for Swedish Men's Ski Team in Davos 2025
Sydney Terror Attack Perpetrated by Father and Son During Chanukka Celebration
The top news stories in Sweden
Delivered straight to your inbox each morning.